Additionally, fibroblast secretion of HGF was found to activate MET and lead to EGFR/MET crosstalk, resulting in resistance to EGFR TKIs in triple-negative breast cancer [111]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.